The Chennai-based company had reported consolidated net profit of Rs 8.21 crore during the same period of the previous year, Shasun Pharmaceuticals said in a BSE filing.
Consolidated total income from operations for the third quarter ended December 31, 2013, rose to Rs 325.28 crore from Rs 270.76 crore registered in the same period of the previous year.
Shares of the company ended at Rs 78.55 apiece down by 1.69 per cent over previous close in BSE.